Sangamo Therapeutics, Inc. · NASDAQ:SGMO
Davis Gregory D had 1,630 Sangamo Therapeutics, Inc. shares withheld for tax (Form 4)
Traded May 25, 2026 · Filed May 27, 2026
On May 25, 2026, Davis Gregory D (Head of Research & Technology) had 1,630 Sangamo Therapeutics, Inc. shares withheld for tax at US$0.17 for US$277, leaving 113,654 shares. Filed May 27, 2026 (Form 4).
- Withheld for tax
- 1,630 shares
- Price
- US$0.17
- Value
- US$277
- Holding after
- 113,654 shares
- Trading plan
- No
- Role
- Head of Research & Technology
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 25, 2026 | Common Stock | Shares withheld for tax | 1,630 | US$0.17 | 113,654 | Direct |
Source
Related
- Sangamo Therapeutics, Inc.
- Davis Gregory D
- Sangamo Therapeutics, Inc. shareholders
- Form 4 · Davis Gregory D · Apr 23, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Jain Nikunj · May 27, 2026
- Form 4 · Dubois-Stringfellow Nathalie · May 27, 2026
- Form 4 · Willoughby Scott B. · May 27, 2026
- Form 4 · Macrae Sandy · May 27, 2026